SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is seeing a dramatic rally, primarily fueled by impending Chinese silver export restrictions and surging industrial demand from sectors like AI. Community sentiment is sharply divided, with many celebrating this as a long-awaited repricing after decades of alleged manipulation, while others warn of an unsustainable, speculative bubble ripe for a significant correction.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

ASPC is experiencing extreme volatility and multiple trading halts, driven by intense speculation around a low-float short squeeze. The community is sharply divided, with bulls anticipating significant gains fueled by high borrow rates, while bears warn of a pump-and-dump and market manipulation.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending amid high anticipation for potential major announcements, including AI partnerships or even a buyout, at the upcoming CES 2026, following its Marigold acquisition and advancements with its AI-powered Athena platform. The community largely views ZETA as a significantly undervalued MarTech company, poised for an explosive breakout and substantial gains in 2026 as it capitalizes on strong fundamentals and AI-driven competitive advantages.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as gold reaches new all-time highs, fueled by persistent geopolitical tensions, a weakening US dollar, and expectations of future Fed rate adjustments. The community is actively debating whether this represents a sustainable 'super cycle' driven by central bank accumulation and a currency reset, or if it signals 'irrational exuberance' that could lead to a significant pullback. Many observers highlight gold's robust performance compared to other asset classes, underscoring its traditional safe-haven appeal amid market uncertainty.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

Universe Pharmaceuticals (UPC) is trending due to its exceptionally low public float, igniting widespread speculation for a potential short squeeze. While many in the community are anticipating significant upward movement, citing a strong cash position and historical volatility, a notable segment of traders warns of it being a 'Chinese pump and dump' scam, with some experiencing broker restrictions on trading.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending amid its deepening "triple threat" partnership with Sidus Space and Nvidia, which recently enabled a major national defense contract win for on-orbit AI capabilities. The community is buzzing about GSIT's Gemini APU, lauded for its unique compute-in-memory architecture and ultra-low power consumption, making it a critical component for real-time edge AI in defense, space, and drone applications. This specialized focus positions GSIT as a compelling player in the rapidly evolving AI hardware landscape, drawing significant attention as investors consider its potential in power-sensitive, mission-critical environments.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending following FDA approval for YARTEMLEA, the first and only therapy for transplant-associated thrombotic microangiopathy (TA-TMA), a critical development expected to unlock significant revenue potential. The community is highly anticipating an upcoming conference call for further guidance, with many discussing strong upside potential, the company's strengthened balance sheet from a major partnership, and a potential short squeeze driving current accumulation.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as silver prices surge to unprecedented levels, yet the stock is experiencing significant lagging performance, sparking intense community discussion. Investors express widespread frustration over the perceived disconnect and market manipulation, but many remain highly bullish, anticipating a substantial "catch-up" rally for miners amid growing industrial demand and global supply constraints.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Trust - ProShares Ultra Silver

ProShares Ultra Silver ($AGQ) is trending amid an intensifying debate around silver's historic price breakout, fueled by robust physical demand, especially from China, and broader economic uncertainties. While many in the community anticipate significant further appreciation as silver 'levels up' its ratio to gold, a vocal segment warns of an overheated market nearing a 'blow off top' and potential manipulation.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as activist investor Toms Capital Investment Management recently disclosed a significant stake, fueling speculation for strategic changes to address the retailer's prolonged sales struggles. The community is split, with some viewing this as a potential catalyst for a turnaround and a deep value opportunity, while others highlight ongoing challenges with sales, management, and competition from rivals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight ratings firms that are currently covering the stock...

Sagimet Biosciences (NASDAQ:SGMT) Stock Price Up 5.4% - Still a Buy?

Sagimet Biosciences (NASDAQ:SGMT) Trading Up 5.4% - Time to Buy...

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment Ascletis Announces...

Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the nine brokerages that are covering the company, Marketbeat reports. One...

Sagimet Biosciences (NASDAQ:SGMT) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of Sagimet Biosciences from a "hold" rating to a "sell" rating in a research note on Saturday...

Insider Selling: Sagimet Biosciences (NASDAQ:SGMT) Chairman Sells 37,688 Shares of Stock

Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) Chairman George Kemble sold 37,688 shares of the company's stock in a transaction on Thursday, November 20th. The shares were sold at an...

George Kemble Sells 37,688 Shares of Sagimet Biosciences (NASDAQ:SGMT) Stock

Sagimet Biosciences Inc. (NASDAQ:SGMT - Get Free Report) Chairman George Kemble sold 37,688 shares of the firm's stock in a transaction that occurred on Thursday, November 20th. The stock was sold at...

Sagimet Biosciences (NASDAQ:SGMT) Releases Earnings Results, Beats Expectations By $0.01 EPS

Sagimet Biosciences (NASDAQ:SGMT - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, beating analysts...

Citizens Jmp Forecasts Strong Price Appreciation for Sagimet Biosciences (NASDAQ:SGMT) Stock

Citizens Jmp upped their price target on Sagimet Biosciences from $33.00 to $35.00 and gave the stock a "market outperform" rating in a report on Friday...

Sagimet Biosciences (NASDAQ:SGMT) Lowered to Hold Rating by Zacks Research

Zacks Research downgraded shares of Sagimet Biosciences from a "strong-buy" rating to a "hold" rating in a research note on Wednesday...

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

SGMT
Sagimet Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SGMT News

SGMTSagimet Biosciences Inc